OS
Embla Medical hf.
OSSFF · OTC
$4.53 +0.00% (+$0.00)
Market Cap $1.93B
P/E Ratio 20.52x
Div. Yield -
ROE 10.52%
Bulios Fair Price
$5.24
15.8% upside
Current Price
$4.53
Undervalued Fair Value Overvalued
According to Bulios Fair Price, OSSFF is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Strong
7/9Valuation
75 /100
Cheap P/FCF 15.08x
P/E 20.52x
P/B 2.09x
Growth
88 /100
Growing FCF growth 50.59%
EPS growth 25.99%
Book val. growth 11.81%
Profitability
73 /100
Strong Op. margin 13.69%
Gross margin 59.30%
FCF margin 13.02%
Quality
44 /100
Average ROA 5.47%
ROIC 6.81%
Asset turnover 0.57x
Debt
65 /100
Moderate Int. coverage 6.59x
Debt/Equity 0.58x
Net debt/EBITDA 2.13x
Stability
91 /100
Stable EPS volatility 12.92%
Beta 0.46x
Profitable years 6
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about OSSFF
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Sveinn Sölvason
Employees
4,192
Headquarters
Reykjavík
Upcoming events
20 OCT
Earnings
Upcoming earnings report